| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 2, Issue 7 311-315, Copyright © 1991 by American Association of Cancer Research
ARTICLES |
A Heguy, C Baldari, K Bush, R Nagele, RC Newton, RJ Robb, R Horuk, JL Telford and M Melli
Sclavo Research Center, Siena, Italy.
The human fibroblast interleukin 1 (IL-1) receptor is a glycosylated transmembrane protein with a cytoplasmic domain of 213 amino acids. We have constructed a series of deletion mutants of the cytoplasmic region of the IL 1 receptor and have used these mutants to examine its role in ligand binding, internalization, signal transduction, and nuclear localization of IL-1. Mutant receptors lacking most of the cytoplasmic domain are expressed at the cell surface and can bind, internalize, and localize IL-1 at the nucleus, but they do not allow IL-1-mediated induction of interleukin 2 and SV40 promoters. We have localized a critical region for signal transduction to a 50-amino acid segment of the cytoplasmic domain of the receptor. These studies demonstrate that IL-1 internalization and nuclear localization are not sufficient to trigger IL-1 activation of gene expression in T-cells.
This article has been cited by other articles:
![]() |
S. M. Sacre, E. Andreakos, M. Feldmann, and B. M. Foxwell Endotoxin signaling in human macrophages: signaling via an alternate mechanism Innate Immunity, December 1, 2004; 10(6): 445 - 452. [Abstract] [PDF] |
||||
![]() |
J. Radons, S. Dove, D. Neumann, R. Altmann, A. Botzki, M. U. Martin, and W. Falk The Interleukin 1 (IL-1) Receptor Accessory Protein Toll/IL-1 Receptor Domain: ANALYSIS OF PUTATIVE INTERACTION SITES BY IN VITRO MUTAGENESIS AND MOLECULAR MODELING J. Biol. Chem., December 5, 2003; 278(49): 49145 - 49153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bourke, A. Cassetti, A. Villa, E. Fadlon, F. Colotta, and A. Mantovani IL-1{beta} Scavenging by the Type II IL-1 Decoy Receptor in Human Neutrophils J. Immunol., June 15, 2003; 170(12): 5999 - 6005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Radons, S. Gabler, H. Wesche, C. Korherr, R. Hofmeister, and W. Falk Identification of Essential Regions in the Cytoplasmic Tail of Interleukin-1 Receptor Accessory Protein Critical for Interleukin-1 Signaling J. Biol. Chem., May 3, 2002; 277(19): 16456 - 16463. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Dinesh-Kumar, W.-H. Tham, and B. J. Baker Structure-function analysis of the tobacco mosaic virus resistance gene N PNAS, December 19, 2000; 97(26): 14789 - 14794. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hofmeister, K. Wiegmann, C. Korherr, K. Bernardo, M. Kronke, and W. Falk Activation of Acid Sphingomyelinase by Interleukin-1 (IL-1) Requires the IL-1 Receptor Accessory Protein J. Biol. Chem., October 31, 1997; 272(44): 27730 - 27736. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |